Scientists have discovered a key protein that could be targeted with a drug to treat the most common and aggressive form of pancreatic cancer. The findings, published in Nature, show that blocking the ...
Cutting edge proton beam therapy is no better than intensity-modulated radiotherapy for treating people with head and neck cancer, according to new research. The nationwide TORPEdO trial funded by ...
On average, we advertise around 15-20 fully-funded PhD opportunities each year. This year we will be advertising our new projects and accepting applications from Wednesday 8th October 2025. Projects ...
We have partnered with Make a Will Online to offer you the opportunity to create a simple Will digitally - at no cost to you. These Wills are checked by a qualified solicitor, providing you with an ...
The Institute of Cancer Research attracts the very best science graduates and clinicians to carry out cutting-edge research and make the discoveries that defeat cancer. Our students enjoy working in a ...
Targeted protein degradation (TPD) has transformed cancer drug discovery by enabling removal of harmful proteins using small molecule degraders. PROTACs (Proteolysis Targeting Chimeras) and MGDs ...
The overuse of CT scans could cause over 100,000 cases of cancer in the US – with almost 10,000 cases in children, researchers have warned. According to a new modelling study, published in the journal ...
A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, ...
The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...
Last month, DeepMind published the much anticipated, detailed methodology underlying the latest version of AlphaFold – the UK-based science company’s powerful AI system that blew away its rivals in ...
Image: DNA sequence. Credit: The Institute of Cancer Research, London. A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for one ...
An immunotherapy combination could be better than standard ‘Extreme’ chemotherapy as first-line treatment for some patients with relapsed or metastatic head and neck cancer, or both, a major phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback